Alexion Pharmaceuticals Inc (ALXN) Price Targets From Analysts
Use the tables below to see what analysts covering Alexion Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 15 | $190 | $155 | $172 | $154.47 | 11.35% |
The Trend in the Analyst Price Target
ALXN's average price target has moved up $33.5 over the prior 302 days.
ALXN reports an average of 19.1% for its upside potential over the past 302 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2020-06-05 | 20 | 170 | 111 | 138.50 | 115.21 | 20.22% |
| 2020-06-11 | 21 | 170 | 111 | 138.81 | 109.82 | 26.4% |
| 2020-06-19 | 20 | 170 | 111 | 138.75 | 119.35 | 16.25% |
| 2020-07-08 | 20 | 170 | 111 | 138.85 | 108.00 | 28.56% |
| 2020-07-18 | 19 | 170 | 111 | 139.37 | 109.24 | 27.58% |
| 2020-07-21 | 19 | 170 | 111 | 139.37 | 107.01 | 30.24% |
| 2020-07-30 | 18 | 175 | 114 | 143.28 | 104.81 | 36.7% |
| 2020-08-12 | 18 | 175 | 114 | 143.28 | 102.78 | 39.4% |
| 2020-08-28 | 18 | 175 | 114 | 143.11 | 106.99 | 33.76% |
| 2020-09-17 | 19 | 175 | 114 | 142.95 | 114.13 | 25.25% |
| 2020-09-21 | 19 | 175 | 114 | 142.95 | 111.74 | 27.93% |
| 2020-10-29 | 21 | 179 | 119 | 144.38 | 118.21 | 22.14% |
| 2020-11-07 | 20 | 179 | 119 | 146.05 | 125.26 | 16.6% |
| 2020-11-19 | 21 | 179 | 119 | 146.38 | 122.05 | 19.93% |
| 2020-12-07 | 20 | 179 | 119 | 145.35 | 118.83 | 22.32% |
| 2020-12-09 | 20 | 179 | 119 | 145.35 | 117.74 | 23.45% |
| 2020-12-19 | 17 | 200 | 125 | 170.71 | 156.75 | 8.91% |
| 2020-12-26 | 17 | 200 | 125 | 170.71 | 152.63 | 11.85% |
| 2021-01-02 | 17 | 200 | 125 | 170.71 | 156.24 | 9.26% |
| 2021-01-09 | 17 | 200 | 140 | 173.65 | 157.35 | 10.36% |
| 2021-01-16 | 17 | 200 | 140 | 173.65 | 156.70 | 10.82% |
| 2021-01-23 | 17 | 200 | 140 | 173.65 | 159.73 | 8.71% |
| 2021-01-30 | 17 | 200 | 140 | 173.65 | 153.33 | 13.25% |
| 2021-02-06 | 17 | 196 | 140 | 172.65 | 153.92 | 12.17% |
| 2021-02-13 | 17 | 196 | 140 | 172.65 | 158.39 | 9% |
| 2021-02-20 | 17 | 196 | 140 | 172.65 | 155.51 | 11.02% |
| 2021-02-27 | 17 | 196 | 140 | 172.65 | 152.75 | 13.03% |
| 2021-03-06 | 17 | 196 | 140 | 172.65 | 150.10 | 15.02% |
| 2021-03-13 | 17 | 196 | 140 | 172.65 | 151.59 | 13.89% |
| 2021-03-20 | 15 | 196 | 155 | 174.67 | 150.94 | 15.72% |
| 2021-04-03 | 15 | 190 | 155 | 172.00 | 153.21 | 12.26% |
ALXN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.94 | 0 | 2 | 15 | 0 | 0 | 17 |
The Trend in the Broker Recommendations
list("500 - Internal server error")
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The average analyst price target of ALXN is higher than 92.8% of all US stocks.
- Alexion Pharmaceuticals Inc's number of analysts covering the stock is greater than 92.96% of Pharmaceutical Products stocks.
- Alexion Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 11.44% of Pharmaceutical Products stocks.
- ALXN has a lower variance in analysts' estimates than 87.89% of stocks in the large market cap category.
In the Pharmaceutical Products industry, PFE, ICPT and ALKS are the three stocks most similar to Alexion Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding ALXN using the data that counts. Try POWR Ratings for free.